Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alex F Herrera

Showing results (41-50 of 175) with videos related to

Pageof 18
Sort By:
British Journal of Haematology|November 19, 2025
Mosunetuzumab is effective and well tolerated in older patients with relapsed/refractory follicular lymphoma: Subgroup analysis of a phase I/II studySwetha Kambhampati Thiruvengadam, Leslie L Popplewell, Alex F Herrera, et al.
Leukemia & Lymphoma|October 10, 2015
Burkitt leukemia limited to the bone marrow has a better prognosis than Burkitt lymphoma with bone marrow involvement in adultsJoo Y Song, Girish Venkataraman, Yuri Fedoriw, et al.
Blood Advances|September 3, 2021
Avelumab in relapsed/refractory classical Hodgkin lymphoma: phase 1b results from the JAVELIN Hodgkins trialAlex F Herrera, Catherine Burton, John Radford, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 19, 2018
Outcomes of Patients with Recurrent and Refractory Lymphoma Undergoing Allogeneic Hematopoietic Cell Transplantation with BEAM Conditioning and Sirolimus- and Tacrolimus-Based GVHD ProphylaxisAmandeep Salhotra, Matthew Mei, Tracey Stiller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2006
Magnetic resonance imaging captures the biology of ductal carcinoma in situLaura J Esserman, Anjali S Kumar, Alex F Herrera, et al.
The New England Journal of Medicine|September 2, 2011
Cord colitis syndrome in cord-blood stem-cell transplantationAlex F Herrera, Gabriela Soriano, Andrew M Bellizzi, et al.
Blood Advances|September 2, 2021
Real-world outcomes of axicabtagene ciloleucel in adult patients with primary mediastinal B-cell lymphomaJennifer L Crombie, Loretta J Nastoupil, Robert Redd, et al.
Haematologica|September 28, 2023
Polatuzumab vedotin plus bendamustine and rituximab or obinutuzumab in relapsed/refractory follicular lymphoma: a phase Ib/II studyChristopher R Flowers, Matthew J Matasar, Alex F Herrera, et al.
Blood Neoplasia|June 19, 2026
Autologous transplant for patients with chemotherapy-sensitive late relapse of diffuse large B-cell lymphomaLorenzo Iovino, Ningxin Ma, Mohamed A Kharfan-Dabaja, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 23, 2024
Phase I Trial of Brentuximab Vedotin Plus Cyclosporine in Relapsed/Refractory Hodgkin LymphomaSwetha Kambhampati Thiruvengadam, Matthew G Mei, Lu Chen, et al.
Pageof 18

Showing results (41-50 of 175) with videos related to

Sort By:
Pageof 18
British Journal of Haematology|November 19, 2025
Mosunetuzumab is effective and well tolerated in older patients with relapsed/refractory follicular lymphoma: Subgroup analysis of a phase I/II studySwetha Kambhampati Thiruvengadam, Leslie L Popplewell, Alex F Herrera, et al.
Leukemia & Lymphoma|October 10, 2015
Burkitt leukemia limited to the bone marrow has a better prognosis than Burkitt lymphoma with bone marrow involvement in adultsJoo Y Song, Girish Venkataraman, Yuri Fedoriw, et al.
Blood Advances|September 3, 2021
Avelumab in relapsed/refractory classical Hodgkin lymphoma: phase 1b results from the JAVELIN Hodgkins trialAlex F Herrera, Catherine Burton, John Radford, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 19, 2018
Outcomes of Patients with Recurrent and Refractory Lymphoma Undergoing Allogeneic Hematopoietic Cell Transplantation with BEAM Conditioning and Sirolimus- and Tacrolimus-Based GVHD ProphylaxisAmandeep Salhotra, Matthew Mei, Tracey Stiller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2006
Magnetic resonance imaging captures the biology of ductal carcinoma in situLaura J Esserman, Anjali S Kumar, Alex F Herrera, et al.
The New England Journal of Medicine|September 2, 2011
Cord colitis syndrome in cord-blood stem-cell transplantationAlex F Herrera, Gabriela Soriano, Andrew M Bellizzi, et al.
Blood Advances|September 2, 2021
Real-world outcomes of axicabtagene ciloleucel in adult patients with primary mediastinal B-cell lymphomaJennifer L Crombie, Loretta J Nastoupil, Robert Redd, et al.
Haematologica|September 28, 2023
Polatuzumab vedotin plus bendamustine and rituximab or obinutuzumab in relapsed/refractory follicular lymphoma: a phase Ib/II studyChristopher R Flowers, Matthew J Matasar, Alex F Herrera, et al.
Blood Neoplasia|June 19, 2026
Autologous transplant for patients with chemotherapy-sensitive late relapse of diffuse large B-cell lymphomaLorenzo Iovino, Ningxin Ma, Mohamed A Kharfan-Dabaja, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 23, 2024
Phase I Trial of Brentuximab Vedotin Plus Cyclosporine in Relapsed/Refractory Hodgkin LymphomaSwetha Kambhampati Thiruvengadam, Matthew G Mei, Lu Chen, et al.
Pageof 18